Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The trade-offs: higher cost, less dose flexibility, and dependence on manufacturer supply
Must register with the FDA as an outsourcing facility Permitted to compound without patient-specific prescriptions (i.e., for office stock) Required to follow cGMP standards Subject to FDA inspections and adverse event reporting Limited to compounding drugs from FDAs 503B bulks list 503B outsourcing facilities are designed for batch compounding at scale, with sterility assurance, standardized quality, and longer beyond-use dates (BUDs) supported by stability data
Results vary from person to person, but mostly people see noticeable improvements after 10-15 sessions, typically taken once or twice a week
We recommend the use of a kitchen scale in cases where precise dosing is required
It all starts with a private, in-depth consultation with our medical team
